These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17084555)

  • 21. Preoperative chemoradiation therapy for low rectal cancer. Impact on downstaging and sphincter-saving operations.
    Habr-Gama A; Perez RO; Kiss DR; Rawet V; Scanavini A; Santinho PM; Nadalin W
    Hepatogastroenterology; 2004; 51(60):1703-7. PubMed ID: 15532809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.
    Valentini V; Coco C; Minsky BD; Gambacorta MA; Cosimelli M; Bellavita R; Morganti AG; La Torre G; Trodella L; Genovesi D; Portaluri M; Maurizi-Enrici R; Barbera F; Maranzano E; Lupattelli M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):403-12. PubMed ID: 17919844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.
    Sun YS; Zhang XP; Tang L; Ji JF; Gu J; Cai Y; Zhang XY
    Radiology; 2010 Jan; 254(1):170-8. PubMed ID: 20019139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim TH; Chang HJ; Kim DY; Jung KH; Hong YS; Kim SY; Park JW; Oh JH; Lim SB; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1158-65. PubMed ID: 19800178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-level downstaging and complete pathologic response after preoperative long-term radiochemotherapy for locally advanced rectal cancer.
    Jonas J; Moroni E; Cavallaro A; Colasanti M; Sautter-Bihl ML; Frenzel H; Lohe B; Bähr R
    G Chir; 2007 Mar; 28(3):65-71. PubMed ID: 17419902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes mellitus affects response to neoadjuvant chemoradiotherapy in the management of rectal cancer.
    Caudle AS; Kim HJ; Tepper JE; O'Neil BH; Lange LA; Goldberg RM; Bernard SA; Calvo BF; Meyers MO
    Ann Surg Oncol; 2008 Jul; 15(7):1931-6. PubMed ID: 18418656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy.
    Agostini M; Pucciarelli S; Enzo MV; Del Bianco P; Briarava M; Bedin C; Maretto I; Friso ML; Lonardi S; Mescoli C; Toppan P; Urso E; Nitti D
    Ann Surg Oncol; 2011 Sep; 18(9):2461-8. PubMed ID: 21416156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.
    Jakobsen A; Mortensen JP; Bisgaard C; Lindebjerg J; Hansen JW; Rafaelsen SR
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):461-5. PubMed ID: 16226396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI tumor volume reduction rate vs tumor regression grade in the pre-operative re-staging of locally advanced rectal cancer after chemo-radiotherapy.
    Neri E; Guidi E; Pancrazi F; Castagna M; Castelluccio E; Balestri R; Buccianti P; Masi L; Falcone A; Manfredi B; Faggioni L; Bartolozzi C
    Eur J Radiol; 2015 Dec; 84(12):2438-43. PubMed ID: 26462793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging.
    Larsen SG; Wiig JN; Emblemsvaag HL; Grøholt KK; Hole KH; Bentsen A; Dueland S; Vetrhus T; Giercksky KE
    Colorectal Dis; 2009 Sep; 11(7):759-67. PubMed ID: 18662240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: treatment with radiotherapy and chemotherapy.
    Burton S; Brown G; Daniels I; Norman A; Swift I; Abulafi M; Wotherspoon A; Tait D
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):445-51. PubMed ID: 16690432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
    Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
    Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.
    Spindler KL; Nielsen JN; Lindebjerg J; Brandslund I; Jakobsen A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):500-4. PubMed ID: 16757132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M
    Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A proposed approach for the selection of the proper surgical therapy to obtain an adequate margin of resection in locally advanced ultra-low rectal cancer after modern preoperative CRX management.
    Echenique I; Cabanillas F; Texidor V; Cáceres J; Isenberg G; Claudio C; Ayala R; Madera F
    Bol Asoc Med P R; 2009; 101(2):53-5. PubMed ID: 19954103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
    Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
    J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated tumor cells in peripheral blood: a novel marker for therapy response in locally advanced rectal cancer patients undergoing preoperative chemoradiation.
    Zitt M; Zitt M; Müller HM; Dinnewitzer AJ; Schwendinger V; Goebel G; De Vries A; Amberger A; Weiss H; Margreiter R; Ofner D; Oberwalder M
    Dis Colon Rectum; 2006 Oct; 49(10):1484-91. PubMed ID: 17019657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.